Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP2 | O95551 | 1/20 | 0.31 |
| ▸ | NSD2 | O96028 | 1/20 | 0.31 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.31 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL803020 | 0.85 | SLC22A8 (0.34) | — | |
| SCHEMBL803047 | 0.77 | ESR1 (0.50) | TDP2NSD2HSP90AA1PAX8 | |
| SCHEMBL5755657 | 0.75 | CYP1A2 (0.31) | TDP2NSD2HSP90AA1PAX8 | |
| Water SCHEMBL22163766 | 0.73 | CYP1A2 (0.30) | TDP2NSD2HSP90AA1PAX8 | |
| Hydrochloric Acid SCHEMBL22129239 | 0.73 | CYP1A2 (0.30) | TDP2NSD2HSP90AA1PAX8 | |
| Bromide SCHEMBL22129268 | 0.73 | CYP1A2 (0.30) | TDP2NSD2HSP90AA1PAX8 | |
| SCHEMBL13923766 | 0.68 | ALDH1A1 (0.47) | TDP2NSD2HSP90AA1PAX8 | |
| SCHEMBL14127999 | 0.68 | NOS3 (0.35) | — | |
| SCHEMBL802741 | 0.66 | ESR1 (0.49) | — | |
| SCHEMBL14967691 | 0.63 | TDP2 (0.43) | TDP2NSD2HSP90AA1PAX8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9096795-B2 | Liquid crystal display | MERCK PATENT GMBH (DE) | 2015-08-04 | — | — | US | disclosed |
| US-20120069289-A1 | LIQUID CRYSTAL DISPLAY | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2012-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120069289-A1 | LIQUID CRYSTAL DISPLAY | LPXN, VCL, ACP3 | TDP2 2485/4885NSD2 1615/4885HSP90AA1 3349/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.